BIO-Europe 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

Tools, data and AI companies at BIO‑Europe 2026

Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website

39 tools, data and AI companies are at BIO-Europe 2026 — 36 presentations on the program. Most represented: Sartorius (2 on the program), Evaluate (1 on the program), Deep Intelligent Pharma (1 on the program). 33 of them have their own page in this guide. As of Nov 10, 2026.

All 473 organizations at BIO-Europe 2026 →

Track
Top represented
Showing 1–19 of 39 organizations
OrganizationBIO-Europe 2026 Attendance
Sartorius
Göttingen, Germany
Tools, data & AI
Supplies bioprocess equipment, consumables and laboratory instruments for biopharmaceutical development and manufacturing.
Panel
Mon Nov 9
14:00–14:45
Community Conversations – Session 1
Attendees join small-group lunch tables on a topic of their choice, from regulatory strategy and global launches to hiring talent and managing partnerships.
with R Kupiec Consulting, Graythan Regulatory Services, Venture Valuation +3 more
Business of BiotechRegulatory Strategy
Panel
Mon Nov 9
15:00–15:45
Community Conversations – Session 2
A second round of the same small-group lunch tables, letting attendees switch to another topic such as regulatory strategy, launches or partnerships.
with R Kupiec Consulting, Graythan Regulatory Services, Venture Valuation +3 more
Business of BiotechRegulatory Strategy
Evaluate
London, United Kingdom
◆Platinum Sponsor
Tools, data & AIPlatinum sponsor
Provides pharmaceutical market intelligence, including sales forecasts, pipeline and deal data.
Panel
Mon Nov 9
17:00–17:45
AI in the Lab: Why Greater Efficiency Could Mean More Drugs, Not Fewer Scientists
Whether AI can speed drug development, not just discovery, how it is changing clinical trials, and whether it will replace some scientists.
with Ingenix, Flagship Pioneering
Ecosystem InnovationBusiness of Biotech
Keynote
Mon Nov 9
12:00–13:00
Building a competitive and impactful European biotech community: Perspectives from the European Life Sciences Coalition, Argenx and Tubulis
How Europe can keep biotech talent, money and companies at home by drawing in big investors, speeding regulation and building stronger stock markets.
with Angelini Ventures, Andera Partners, Tubulis +1 more
Ecosystem InnovationBusiness of Biotech
◆Platinum Sponsor
Tools, data & AIPlatinum sponsor
AI company offering AI-powered clinical development services and software, from protocol design and data management to regulatory documents.
Talk
Mon Nov 9
09:00–10:00
Doctor-to-Doctor: A PI-Led Pathway into Japan Using AI, DCT, and Registration-Directed Investigator-Initiated Trials to Reach Japanese Patients Faster
How trials led by the right Japanese doctor, rather than a contract research company, can take a drug toward approval in Japan.
Clinical StrategyRegulatory Strategy
◇Silver Sponsor
Tools, data & AISilver sponsor
AI platform that gathers scientific evidence and applies diligence frameworks to help pharma, biotech and deal teams evaluate drug assets.
Panel
Tue Nov 10
14:00–14:25
Faster, Sharper, More Competitive: How Pharma BD Is Evolving and How Biotechs Can Keep Pace
How pharma deal teams now screen incoming biotech offers with new tools, and what a well-prepared biotech pitch looks like today.
with Astellas, CSL
◇Silver Sponsor
Tools, data & AISilver sponsor
Clinical trial planning software and data covering patient, country and site feasibility, for pharma and biotech companies and contract research organizations.
Panel
Tue Nov 10
15:00–15:25
Expanding Global Clinical Trials: Opportunities and Challenges in Emerging Markets
How to expand clinical trials into emerging markets and underserved groups, from picking contract research companies and sites to building local partnerships.
3DBioFibR
Halifax, Canada
Tools, data & AI
Makes collagen fibers used in 3D bioprinting, cell culture scaffolds and tissue engineering.
Panel
Mon Nov 9
14:00–14:25
Get in the Mix with Canada’s Picks: Innovation in Life Sciences
Selected Canadian companies present their health technologies, alongside an overview of Canada's life sciences sector and its partnership opportunities.
with Government of Canada, Government of Ontario, Life Sciences BC +3 more
A-Alpha Bio
Seattle, WA
Tools, data & AI
Measures protein–protein interactions at large scale and uses the data with machine learning to help engineer protein medicines.
Talk
Tue Nov 10
14:15–14:30
Antibodies: A-Alpha Bio
Lab and AI tools that measure and predict how strongly millions of protein pairs bind, used to design biologics and molecular glues.
AB Cube
Paris, France
Tools, data & AI
Software group making clinical trial data management software and SafetyEasy, a cloud system for processing and reporting drug-safety cases.
Talk
Tue Nov 10
15:30–15:45
Technologies and Tools: AB Cube
Software that links clinical trial data capture with drug-safety reporting, so adverse events in a trial flow straight into safety case files.
Tools, data & AI
Offers an AI platform that analyses omics data for researchers without any coding.
Talk
Wed Nov 11
09:40–09:50
Drug Discovery and Development: aimed analytics GmbH
Software that lets research teams ask plain-language questions of large biological datasets and get reusable AI-built analyses without coding.
AinB
Gwacheon, South Korea
Tools, data & AI
Korean company using AI to design and optimise antibodies and to improve how antibodies are produced.
Talk
Tue Nov 10
14:30–14:45
Antibodies: AinB
A Seoul company whose AI designs lab-tested antibody drug candidates in 28 days and retrains on every new experiment.
AlphaSense
New York, New York
Tools, data & AI
Market intelligence platform using AI search across company filings, broker research, expert call transcripts and news.
Panel
Mon Nov 9
13:00–13:45
The therapeutic landscape backed by analyst insights
Which disease areas analysts rate most promising for new drugs and investment, and how new science and rule changes are reshaping them.
with Thuja Capital, Ipsen, Medicxi
Tools, data & AI
Uses machine learning to engineer proteins, raising production yield and quality for research tools and therapeutics.
Talk
Tue Nov 10
13:00–13:15
Technologies and Tools: Avenue Biosciences
Protein engineering and machine learning, trained on a large lab dataset, to improve how mammalian cells produce and secrete therapeutic proteins.
Tools, data & AI
Builds physics-informed AI models that predict how strongly drug molecules bind their targets, and their other chemical properties.
Talk
Tue Nov 10
14:45–15:00
Technologies and Tools: Azulene Labs
A company whose physics-based AI models predict how tightly drug molecules bind their targets, even for unusual chemistry with little lab data.
Tools, data & AI
Information and analytics company providing life sciences and healthcare data, market research and intellectual property services.
Panel
Tue Nov 10
14:30–14:55
The Next Generation of European Entrepreneurs: From Scientific Innovation to Life Sciences Impact
What makes a successful life sciences founder, and how founders in Europe can turn discoveries into biotech companies that compete worldwide.
with ATHOS, Melodia Therapeutics
Concr
Cambridge, United Kingdom
Tools, data & AI
Software company modelling biological risk in cancer drug development.
Talk
Wed Nov 11
10:30–10:40
Biomarkers/Diagnostics/Imaging: Concr
AI borrowed from astrophysics that builds virtual copies of cancer patients from sparse data to guide biomarker work and simulate clinical trials.
Tools, data & AI
Makes single-molecule analysis devices that read antibody quality, such as titer, glycosylation and aggregation, from the first days of cell line development.
Talk
Tue Nov 10
14:00–14:15
Technologies and Tools: Constellate Proteomics
Devices that read antibody drug samples one molecule at a time, measuring yield, sugar groups, clumping and charge from the start of development.
Tools, data & AI
Swiss company whose FluidFM technology works on single living cells at nanoscale precision, for cell analysis and genome editing.
Talk
Tue Nov 10
17:00–17:15
Drug Discovery and Development: Cytosurge AG
A Swiss company that reads a living cell's active genes without killing it, so one cell can be compared before and after a change.
Tools, data & AI
Software company building digital-twin simulations of clinical trials to test drug development decisions before running them.
Panel
Tue Nov 10
13:00–13:55
Unlocking APACs Clinical Trials Potential: Navigating Regulatory Pathways, Bridging Strategies and Market Access Across the Region
How to run clinical trials and win approval in Japan, Korea, Taiwan and Southeast Asia, and when studies in local patients pay off.
with Graythan Regulatory Services, HiRO, CMIC Group
Tools, data & AI
AI drug discovery company offering first-in-class discovery, allosteric and dual-target drug design, and its BioTrajectory AI platform.
Talk
Tue Nov 10
16:00–16:15
Autoimmune/Inflammation: Divamics Inc.
Drug discovery that combines AI with molecular dynamics simulations of how molecules move, to find new lead compounds faster.

Explore the full BIO-Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Cologne. Leave your work email and we’ll be in touch.

Privacy

Download the full BIO-Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find buyers from tools, data and AI companies

Tell us what you sell and we’ll find the people at these tools, data and AI companies most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Browse BIO-Europe 2026 by

Not affiliated with or endorsed by BIO-Europe or its organizers. Submit a correction